The Chemours Company Financial Statements (CC)
|
|
|
|
Report date
|
|
|
11.02.2022 |
10.02.2023 |
27.03.2024 |
18.02.2025 |
24.02.2026 |
|
05.05.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
6 345 |
6 831 |
6 078 |
5 782 |
5 808 |
|
5 821 |
|
Operating Income, bln rub |
|
|
674.0 |
786.0 |
-123.0 |
443.0 |
-5.00 |
|
-19.0 |
|
EBITDA, bln rub |
? |
|
1 178 |
1 195 |
197.0 |
692.0 |
332.0 |
|
170.0 |
|
Net profit, bln rub |
? |
|
608.0 |
578.0 |
-238.0 |
86.0 |
-386.0 |
|
-411.0 |
|
|
OCF, bln rub |
? |
|
814.0 |
755.0 |
556.0 |
-633.0 |
264.0 |
|
332.0 |
|
CAPEX, bln rub |
? |
|
277.0 |
307.0 |
370.0 |
360.0 |
213.0 |
|
178.0 |
|
FCF, bln rub |
? |
|
537.0 |
448.0 |
186.0 |
-993.0 |
51.0 |
|
154.0 |
|
Dividend payout, bln rub
|
|
|
164.0 |
154.0 |
149.0 |
148.0 |
78.0 |
|
54.0 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
27.0% |
26.6% |
0.00% |
172.1% |
0.00% |
|
0.00% |
|
|
OPEX, bln rub |
|
|
707.0 |
830.0 |
1 429 |
708.0 |
907.0 |
|
900.0 |
|
Cost of production, bln rub |
|
|
4 964 |
5 215 |
4 772 |
4 631 |
4 906 |
|
4 940 |
|
R&D, bln rub |
|
|
107.0 |
118.0 |
108.0 |
109.0 |
108.0 |
|
107.0 |
|
Interest expenses, bln rub |
|
|
185.0 |
163.0 |
208.0 |
264.0 |
269.0 |
|
271.0 |
|
|
Assets, bln rub |
|
|
7 550 |
7 640 |
8 251 |
7 515 |
7 382 |
|
7 267 |
|
Net Assets, bln rub |
? |
|
1 081 |
1 107 |
737.0 |
604.0 |
250.0 |
|
215.0 |
|
Debt, bln rub |
|
|
3 987 |
3 880 |
4 299 |
4 355 |
4 585 |
|
4 391 |
|
Cash, bln rub |
|
|
1 451 |
1 102 |
1 203 |
713.0 |
672.0 |
|
563.0 |
|
Net debt, bln rub |
|
|
2 536 |
2 778 |
3 096 |
3 642 |
3 913 |
|
3 828 |
|
|
Ordinary share price, rub |
|
|
33.6 |
30.6 |
31.5 |
16.9 |
11.8 |
|
22.0 |
|
Number of ordinary shares, mln |
|
|
164.9 |
155.4 |
148.9 |
149.5 |
150.4 |
|
150.4 |
|
|
Market cap, bln rub |
|
|
5 536 |
4 757 |
4 697 |
2 526 |
1 773 |
|
3 312 |
|
EV, bln rub |
? |
|
8 072 |
7 535 |
7 793 |
6 168 |
5 686 |
|
7 140 |
|
Book value, bln rub |
|
|
973 |
992 |
632 |
555 |
202 |
|
167 |
|
|
EPS, rub |
? |
|
3.69 |
3.72 |
-1.60 |
0.58 |
-2.57 |
|
-2.73 |
|
FCF/share, rub |
|
|
3.26 |
2.88 |
1.25 |
-6.64 |
0.34 |
|
1.02 |
|
BV/share, rub |
|
|
5.90 |
6.39 |
4.24 |
3.71 |
1.34 |
|
1.11 |
|
|
EBITDA margin, % |
? |
|
18.6% |
17.5% |
3.24% |
12.0% |
5.72% |
|
2.92% |
|
Net margin, % |
? |
|
9.58% |
8.46% |
-3.92% |
1.49% |
-6.65% |
|
-7.06% |
|
FCF yield, % |
? |
|
9.70% |
9.42% |
3.96% |
-39.3% |
2.88% |
|
4.65% |
|
ROE, % |
? |
|
56.2% |
52.2% |
-32.3% |
14.2% |
-154.4% |
|
-191.2% |
|
ROA, % |
? |
|
8.05% |
7.57% |
-2.88% |
1.14% |
-5.23% |
|
-5.66% |
|
|
P/E |
? |
|
9.10 |
8.23 |
-19.7 |
29.4 |
-4.59 |
|
-8.06 |
|
P/FCF |
|
|
10.3 |
10.6 |
25.3 |
-2.54 |
34.8 |
|
21.5 |
|
P/S |
? |
|
0.87 |
0.70 |
0.77 |
0.44 |
0.31 |
|
0.57 |
|
P/BV |
? |
|
5.69 |
4.80 |
7.43 |
4.55 |
8.78 |
|
19.8 |
|
EV/EBITDA |
? |
|
6.85 |
6.31 |
39.6 |
8.91 |
17.1 |
|
42.0 |
|
Debt/EBITDA |
|
|
2.15 |
2.32 |
15.7 |
5.26 |
11.8 |
|
22.5 |
|
|
R&D/CAPEX, % |
|
|
38.6% |
38.4% |
29.2% |
30.3% |
50.7% |
|
60.1% |
|
|
CAPEX/Revenue, % |
|
|
4.37% |
4.49% |
6.09% |
6.23% |
3.67% |
|
3.06% |
|
| The Chemours Company shareholders |
